Daniel J. Brennan - 16 Feb 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP and CFO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
16 Feb 2024
Net transactions value
-$1,086,974
Form type
4
Filing time
20 Feb 2024, 21:03:40 UTC
Previous filing
16 Feb 2024
Next filing
23 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +4,243 +1.6% $0.000000 268,812 16 Feb 2024 Direct F1
transaction BSX Common Stock Tax liability $123,873 -1,882 -0.7% $65.82 266,930 16 Feb 2024 Direct
transaction BSX Common Stock Options Exercise $0 +4,583 +1.7% $0.000000 271,513 17 Feb 2024 Direct F1
transaction BSX Common Stock Tax liability $133,812 -2,033 -0.75% $65.82 269,480 17 Feb 2024 Direct
transaction BSX Common Stock Options Exercise $0 +3,706 +1.4% $0.000000 273,186 18 Feb 2024 Direct F2
transaction BSX Common Stock Tax liability $108,208 -1,644 -0.6% $65.82 271,542 18 Feb 2024 Direct
transaction BSX Common Stock Options Exercise $178,699 +13,662 +5% $13.08 285,204 20 Feb 2024 Direct
transaction BSX Common Stock Sale $899,779 -13,662 -4.8% $65.86 271,542 20 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -4,243 -33% $0.000000 8,486 16 Feb 2024 Common Stock 4,243 Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -4,583 -50% $0.000000 4,584 17 Feb 2024 Common Stock 4,583 Direct F1, F4
transaction BSX Deferred Stock Units Options Exercise $0 -3,706 -100% $0.000000* 0 18 Feb 2024 Common Stock 3,706 Direct F2, F5
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -13,662 -100% $0.000000* 0 20 Feb 2024 Common Stock 13,662 $13.08 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
F6 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.